Press releases

Company expects to receive the net offering proceeds upon closing on August 13, 2013, subject to customary closing conditions.

"As we continue to expand our portfolio, our team is inspired to deliver meaningful innovation to more patients globally," said president and CEO Mike Mahoney.

System is next-generation 3D mapping and navigation solution for use in cardiac catheter ablations and other electrophysiology (EP) procedures.

Next generation intravascular ultrasound catheter improves image quality and deliverability

First patient treated in OPTIMISE clinical trial evaluating safety, efficacy of occipital nerve stimulation using Precision™ system.